Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Assets (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Assets for 15 consecutive years, with $726.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Assets rose 8.24% to $726.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $726.6 million, a 8.24% increase, with the full-year FY2024 number at $748.2 million, up 18.24% from a year prior.
  • Assets was $726.6 million for Q3 2025 at Usana Health Sciences, down from $734.5 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $748.2 million in Q4 2024 to a low of $556.1 million in Q4 2022.
  • A 5-year average of $629.4 million and a median of $604.1 million in 2023 define the central range for Assets.
  • Peak YoY movement for Assets: rose 23.98% in 2021, then dropped 9.85% in 2022.
  • Usana Health Sciences' Assets stood at $578.9 million in 2021, then rose by 3.04% to $596.5 million in 2022, then increased by 6.07% to $632.8 million in 2023, then grew by 18.24% to $748.2 million in 2024, then dropped by 2.89% to $726.6 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Assets are $726.6 million (Q3 2025), $734.5 million (Q2 2025), and $746.6 million (Q1 2025).